Intravenous Immunoglobulin (IVIG) and Blood-Brain Barrier Disruption in Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT07193953 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07193953
- Sponsor
- Sunnybrook Health Sciences Centre
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-15
- Primary completion
- 2026-11-30
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.